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T reg cells that express the transcription factor 
Foxp3 are critical for preventing autoimmunity 
by dampening self-reactive immune responses 
(Sakaguchi et al., 2008). Their role in infections, 
however, is complex. On the one hand, activated 
T reg cells protect the host by curbing inflam-
mation and limiting collateral tissue damage, but 
on the other hand by limiting host immunity, 
they can also inhibit pathogen clearance. T reg 
cells dampen immune responses in a wide range 
of infections caused by bacteria, fungi, parasites, 
and viruses, especially those that persist in the 
host (Belkaid and Tarbell, 2009).
Mycobacterium tuberculosis (Mtb) is one of   
the most formidable persistent pathogens and a 
major cause of morbidity and mortality world-
wide (WHO, 2008). The role of T reg cells in 
facilitating Mtb persistence is still unclear. Ini-
tially, after inhalation of infectious bacilli, T reg 
numbers are reduced in the peripheral blood of 
asymptomatic individuals, and this decrease has 
been attributed to their accumulation at sites of 
infection in the lung (Burl et al., 2007). Later, 
during active tuberculosis (TB), T reg cell num-
bers are increased in the peripheral blood and 
infected  tissues  (Guyot-Revol  et  al.,  2006;   
Ribeiro-Rodrigues et al., 2006), and T reg cells 
isolated  from  infected  individuals  are  capable   
of suppressing T cell responses to Mtb antigens 
in vitro (Chen et al., 2007; Hougardy et al., 
2007). Recent studies in the mouse model have 
further clarified the role of T reg cells in TB, es-
pecially during the first 4 wk of infection, a criti-
cal period in which containment of Mtb by the 
immune system is established. We have shown 
that rigorous depletion of T reg cells during early 
infection results in enhanced bacterial clearance 
(Scott-Browne et al., 2007), whereas Kursar   
et al. (2007) reported similar results when they 
transferred T reg–depleted CD4+ T cells into 
lymphopenic recipients. Although these studies 
reveal that T reg cells deter the clearance of Mtb 
during early infection, the basic rules governing 
T reg cell activity during this period, including 
their specificity and mode of immunosuppres-
sion, remain unknown.
With respect to their specificity in TB, as in 
other infections, it is unclear whether T reg cells 
need to recognize pathogen-derived antigens   
to proliferate and suppress immunity. Because   
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The ability of the adaptive immune system to restrict Mycobacterium tuberculosis (Mtb) is 
impeded by activated Foxp3+ regulatory T (T reg) cells. The importance of pathogen-specific 
T reg cells in this process has not been addressed. We show that T reg cell expansion after 
aerosol Mtb infection does not occur until Mtb is transported to the pulmonary lymph node 
(pLN), and Mtb-specific T reg cells have an increased propensity to proliferate. Even small 
numbers of Mtb-specific T reg cells are capable of delaying the priming of effector CD4+ and 
CD8+ T cells in the pLN and their subsequent accumulation in the lung, the primary site of 
infection. This delay likely prolongs the initial phase of bacterial expansion and explains the 
higher bacterial burden observed in these mice. Thus, T reg cells recognizing Mtb-derived 
antigens specifically and potently restrict protective immune responses during tuberculosis.
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tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1410 Mtb-specific T reg cells impair TB immunity | Shafiani et al.
delaying the appearance of Mtb-specific effector T cells in the 
lung. Our data support a model in which the timeliness of   
effector T cell recruitment to the lung is critical for establishing 
immune control of Mtb infection, and Mtb-specific T reg cells 
slow the rate at which this recruitment occurs.
RESULTS
T reg cells responding during early Mtb infection  
are derived from preexisting T reg cells
To investigate whether Mtb-specific, conventional CD4+  
T cells are induced to express Foxp3 during the early immune 
response to Mtb, we obtained P25 TCR transgenic mice con-
taining CD4+ T cells specific for an immunodominant Mtb 
antigen, Ag85B240–254:I-Ab (Tamura et al., 2004; Ariga et al., 
2007). To verify that P25 T cells undergo antigen-specific 
proliferation in Mtb-infected mice, we transferred CFSE- 
labeled P25 T cells into mice recently infected with either Mtb 
(WT) or a recombinant strain that lacks expression of Ag85B, 
Mtb (Ag85B KO). In agreement with a recent report (Wolf   
et al., 2008), we observed that P25 T cells proliferated only   
in mice infected with Mtb expressing Ag85B (Fig. 1 A), con-
firming that P25 T cells undergo robust antigen-driven expan-
sion during TB. To address whether T reg cells are generated 
de novo during the expansion of Mtb-specific CD4 T cells, 
we  backcrossed  P25  mice  to  Foxp3-GFP  reporter  mice 
(CD45.1 expressing) so that T reg cells could be readily iden-
tified by virtue of their green fluorescence (Fontenot et al., 
2005). Foxp3-GFPneg CD4+ cells from P25 mice were trans-
ferred into B6 mice recently infected with Mtb or into unin-
fected controls. At day 26 after infection, transferred CD4+ 
P25 cells that expressed the transgenic TCR recognized by 
KN7, an anticlonotypic antibody, were analyzed for their   
expression of Foxp3. As expected, we observed dramatically 
higher numbers of KN7+ P25 cells in the spleens, pLNs, and 
lungs of infected mice compared with tissues from uninfected 
controls. Despite this expansion, induction of Foxp3 within 
these Mtb-specific CD4+ T cells was not observed (Fig. 1 B).
To confirm that these results using TCR transgenic T cells 
were true for endogenous CD4+ T cells, we also transferred 
polyclonal T cell populations from nontransgenic mice into 
Mtb-infected mice. 11 d after aerosol infection, conventional 
CD4+ T cells (Thy1.2 CD45.2 CD4+Foxp3-GFPneg cells) 
and T reg cells (Thy1.2 CD45.1 CD4+Foxp3-GFP+ cells) 
from uninfected Foxp3-GFP mice were cotransferred into 
Mtb-infected, Thy1.1 recipients (Fig. 2 A). On day 28 after 
infection, spleen cells were analyzed after magnetic bead   
enrichment of transferred Thy1.2 cells, whereas pLN and 
lung cells were analyzed directly. Thy1.2 CD4+ cells from each 
organ were examined to determine the percentage of CD45.2 
(blue gates and histograms; transferred as Foxp3 cells) and 
CD45.1 (red gates and histograms; transferred as Foxp3+ cells) 
cells that expressed Foxp3 (Fig. 2 B). Although most of the 
transferred Foxp3+ cells retained their Foxp3 expression, in-
duction of Foxp3 in conventional CD4+ T cells was not ob-
served.  Together  with  our  results  using  TCR  transgenic   
T cells (Fig. 1), our data indicate that T reg cells responding 
T reg cells are believed to have a relatively high affinity for self-
antigens (Hsieh et al., 2004; Bautista et al., 2009; DiPaolo and 
Shevach, 2009), recognition of self-antigens may be sufficient 
to drive their expansion and function during the inflammatory 
milieu of TB. Conversely, T reg cells that recognize Mtb anti-
gens may play a predominant role in TB. Although pathogen-
specific T reg cells have been convincingly demonstrated during 
Leishmania major infection (Suffia et al., 2006), and implicated in 
several other infections (Belkaid and Tarbell, 2009), the unique 
functional properties of pathogen-specific T reg cells are not 
well understood.
Furthermore, the mechanisms by which T reg cells inter-
fere with immune protection against infection remain un-
clear. In TB, infection occurs by inhalation of respiratory 
droplets containing only a few bacilli, which undergo robust 
replication within lung macrophages before the onset of 
adaptive immunity (Cooper, 2009). The adaptive immune 
response is initiated only when Mtb is transported to the pul-
monary LN (pLN) between days 8 and 11 after infection 
(Chackerian et al., 2002; Wolf et al., 2007; Reiley et al., 
2008). Mtb-specific effector T cells are primed in the LN, 
expand their numbers, and traffic to the lung, where they re-
cognize their specific antigens presented by infected macro-
phages and dendritic cells (Cooper, 2009). These activated   
T cells produce protective cytokines, including IFN-, that 
promote macrophage activation and curtail mycobacterial 
growth, but they fail to achieve Mtb eradication. Instead, 
bacterial numbers are held constant during persistent infec-
tion, though this plateau is not established until approximately 
day 21 after infection. Thus, adaptive immunity develops 
much slower during Mtb infection than in other infections, 
allowing the bacteria to establish a foothold in the lung 
(Cooper, 2009). There is a tight correlation between the ra-
pidity of the appearance of Mtb-specific T cells in the lung 
and the ability to establish immune control. Early arrival of 
Mtb-specific T cells, including after immunization, is associ-
ated with enhanced immune control and lower bacterial bur-
dens (Jung et al., 2005, 2008; Gallegos et al., 2008), whereas 
delayed arrival is associated with a higher infection plateau 
(Caruso et al., 1999; Chackerian et al., 2001, 2002). Mtb-
specific Th17 cells have been shown to facilitate the rapid   
recruitment of Mtb-specific T cells to the lungs of immunized 
mice, thereby promoting immune protection and lowering 
bacterial burdens (Khader et al., 2007).
In this study, we hypothesized that T reg cells may have 
the opposite effect of Th17 cells and impede the effector T cell 
response by delaying their arrival. Furthermore, we hypothe-
sized that T reg cells recognizing Mtb antigens would have an 
increased capacity to mediate this effect. To address these ques-
tions, we performed transfer experiments using Mtb-specific 
TCR transgenic T cells to examine T reg cell origin, specific-
ity, and influence on effector T cell recruitment during early 
Mtb infection. Our data indicate that T reg cells expand from 
the preexisting population and that pathogen-specific T reg 
cells proliferate preferentially. Furthermore, even low numbers 
of Mtb-specific T reg cells can impair immune protection by JEM VOL. 207, July 5, 2010 
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drives T reg cell proliferation at earlier time points. To 
address this question, we administered the nucleotide ana-
logue BrdU intraperitoneally to Mtb-infected mice at various 
time points after aerosol infection. Mice were analyzed 20 h 
later, and the percentages of CD4+Foxp3+ and CD4+Foxp3 
cells that incorporated BrdU in the pLN and lung were de-
termined (Fig. 3). Before infection, T reg cells had a higher 
level of basal proliferation than conventional CD4+Foxp3  
T cells, especially in the lung. Surprisingly, T reg cells in the lung 
actually exhibited decreased proliferation for the first 16 d   
after infection but then dramatically increased proliferation on 
day 21. Overall, T reg cells displayed a delay in proliferation 
during the early stages of Mtb infection are not generated   
de novo but expand from preexisting T reg cells.
Expansion of T reg cells after aerosol Mtb infection is delayed
We previously showed that T reg cells display an increased 
rate of proliferation between days 21 and 35 after infection 
(Scott-Browne et al., 2007). However, when T reg cell pro-
liferation is initiated has not been addressed. Expansion of   
effector T cells does not occur until after Mtb is transported 
to the pLN, which begins to occur on days 8–11 after infec-
tion (Chackerian et al., 2002; Wolf et al., 2007; Reiley et al., 
2008). It is unknown whether T reg cell expansion is also 
delayed or whether the inflammatory milieu in the lung 
Figure 1.  Foxp3 expression is not induced in Mtb-specific, trans-
genic CD4+ T cells during early Mtb infection. (A) Proliferation of 
CFSE-labeled CD4+ T cells (105 cells transferred) from CD45.1 P25 TCR 
transgenic mice (analyzed on day 18 after infection) 6 d after transfer into 
Mtb (WT)– or Mtb (Ag85B KO)–infected B6 mice. Numbers represent the 
percentage of proliferating CD45.1 CD4+ T cells in the spleen as measured 
by CFSE dilution. (B, top) Transgenic TCR (detected by KN7 anticlonotypic 
antibody for the P25 transgenic TCR) and CD45.1 expression on gated CD4+ 
cells from the spleen, pLN, and lung of Mtb-infected B6 mice, transferred 
on day 11 and analyzed on day 26 after infection. Numbers shown above 
the gray gates represent the percentage of transferred KN7+ CD45.1 cells 
within the CD4+ cells in each tissue, and the numbers shown in parenthesis 
below the gates represent the corresponding percentages in uninfected 
controls. (bottom) The expression of CD25 and Foxp3 by cells within the 
KN7+ CD45.1 population; numbers represent the percentage of Foxp3+ cells 
within this gate. Each experiment was performed three times with three 
Mtb-infected mice per group. Results from representative mice are shown.
Figure 2.  Foxp3 expression is not induced in endogenous CD4+  
T cells during early Mtb infection. (A) Schematic of experimental  
design. 2.5 × 106 conventional CD4+ T cells (blue) and 5 × 105 T reg cells 
(red) were transferred on day 11 and analyzed on day 28 after infection. 
(B, top) Gated CD4+ T cells; the gray gate represents the transferred 
Thy1.2 cells within these populations in the enriched spleen, pLN, and 
lung. (middle) CD45.2 (blue gate) and CD45.1 cells (red gate) within the 
Thy1.2 populations. (bottom) Foxp3-GFP expression within CD45.2 (blue 
histograms, representing cells sorted and transferred as Foxp3-GFPneg 
cells) and CD45.1 cells (red histograms, representing cells sorted and 
transferred as Foxp3-GFP+ cells). Percentages of cells are shown.  
The experiment was performed three times with three mice per group  
in each experiment. Results from representative mice are shown.1412 Mtb-specific T reg cells impair TB immunity | Shafiani et al.
was noted to be a good marker for identifying T reg 
cells in P25 mice; 80% of Foxp3+ cells in P25 
mice  expressed  CD25,  and  >95%  of  CD25- 
expressing CD4 cells were Foxp3+ (Fig. 4 B). Col-
lectively, we reasoned that the dual specificity of 
P25 T reg cells (i.e., specificity for an Mtb antigen and self- 
ligand) could be exploited to determine whether T reg cells 
bearing  a  pathogen-specific  TCR  have  unique  functional 
properties, or whether all CD4+Foxp3+ cells are capable of   
responding equally during TB.
Pathogen-specific T reg cells exhibit preferential 
proliferation during TB
Having previously shown that T reg cell expansion is delayed 
until presentation of Mtb antigens has occurred in the pLN 
(Fig. 3), we wanted to determine if T reg cells specific for 
Mtb-derived antigens showed preferential expansion. Alter-
natively, because T reg cells express TCRs with relatively 
high affinities for self-antigens (Hsieh et al., 2004; Bautista   
et al., 2009; DiPaolo and Shevach, 2009) and exhibit an acti-
vated phenotype (Sakaguchi et al., 2008), it is possible that all 
T reg cells are driven to proliferate by the inflammatory cyto-
kine milieu in TB. To test these possibilities, CD4+CD25+  
T cells from CD45.2 P25 mice were labeled with CFSE and 
transferred into CD45.1 recipients infected with either Mtb 
(WT) or Mtb (Ag85B KO), which is equally virulent (Wolf   
et al., 2008). As additional controls, CD4+CD25+ T cells   
from P25 mice were transferred into uninfected mice, and 
CD4+CD25+ T cells from TCR transgenic mice with an   
irrelevant antigen specificity (i.e., SMARTA mice with CD4+ 
T cells recognizing an epitope of lymphocytic choriomenin-
gitis virus glycoprotein presented by I-Ab; Oxenius et al., 
1998) were transferred into Mtb-infected mice. To examine 
the period in which endogenous T reg cells were observed to 
initiate proliferation (Fig. 3), we transferred T reg cells on day 
15 after infection and assessed proliferation on day 20. Because 
we transferred small numbers of T reg cells, we used magnetic 
bead enrichment to analyze most of the transferred CD45.2   
T cells in an entire spleen (Hataye et al., 2006). As shown in 
Fig. 5 A, we found that T reg cells from P25 mice did not 
in both the pLN and lung that was very similar to that ob-
served for conventional CD4+ T cells. The fact that T reg cell 
expansion is not initiated until after presentation of Mtb anti-
gens in the pLN begins to occur raises the possibility that   
T reg cells responding during early TB are Mtb specific.
P25 mice contain a population of Mtb-specific T reg cells
We next sought to directly test whether Mtb-specific T reg 
cells have a greater capacity to proliferate and affect protective 
immunity than polyclonal T reg cells during the early response 
to Mtb infection. The specificity of T reg cells in P25 mice was 
examined to determine if these cells could be used to address 
this question. As shown in Fig. 4 A, 40% of the CD4+Foxp3+ 
cells in spleens of P25 mice, comprising 2% of the total CD4+ 
T cells, also expressed the transgenic TCR conferring speci-
ficity for Ag85B240–254/I-Ab. Because T reg cell development   
is thought to result from relatively high affinity TCR interac-
tions with self-antigen–MHC complexes in the thymus (Hsieh 
et al., 2004; Bautista et al., 2009; DiPaolo and Shevach, 2009), 
we suspected that expression of endogenous TCRs was re-
quired to direct this process in P25 mice, as has been shown in 
other TCR transgenic mice (Thornton and Shevach, 2000; 
Hori et al., 2002; Eggena et al., 2004; Chen et al., 2005; Schenk 
et al., 2005). Consistent with this idea, we found that P25   
mice lacking the ability to rearrange their endogenous TCR   
loci (i.e., on a RAG2/ background) possessed very few 
CD4+Foxp3+ T cells (Fig. 4 A). These results support the idea 
that T reg cells in P25 mice are not only Mtb-specific by virtue 
of their expression of the transgenic TCR, but represent a 
polyclonal population of T reg cells that also express endoge-
nous TCRs that drive the expression of Foxp3 during thymic 
development. Furthermore, we found that P25 T reg cells   
expressed levels of CD25, CD103, CTLA-4, and GITR that 
were similar to patterns observed in the polyclonal population 
of T reg cells in B6 mice. In particular, as in B6 mice, CD25 
Figure 3.  Proliferation of endogenous T reg cells is 
delayed similarly to effector T cell proliferation.  
(A) Representative BrdU incorporation of CD4+-gated T cells 
in the pLNs (top) or lungs (bottom) of uninfected or Mtb-
infected mice at various time points after aerosol infection. 
Mice were administered 1 mg BrdU intraperitoneally 20 h 
before analysis. Numerical values represent the percentage 
of Foxp3+ (top right quadrant) and Foxp3 cells (bottom 
right quadrant) that incorporated BrdU. (B) Cumulative data 
showing the frequency of Foxp3-expressing CD4+ T cells 
(squares) and Foxp3 CD4+ T cells (triangles) that incorpo-
rated BrdU in the pLNs or lungs of mice at various time 
points after Mtb infection. Means and SEM of three mice per 
group at each time point are shown. Data are representative 
of two independently performed experiments.JEM VOL. 207, July 5, 2010 
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points  examined,  Mtb  (WT)–infected  mice  receiving  P25   
T reg cells had an increased lung bacterial burden (0.7 log) 
compared with controls receiving no transferred T reg cells 
(Fig. 6). In contrast, P25 T reg cells had no effect on the   
bacterial burden in the lungs of Mtb (Ag85B KO)–infected 
mice. Likewise, at day 35 after infection, conventional T cells 
(CD4+CD25neg) from P25 mice and T reg cells (CD4+CD25+) 
from SMARTA mice had no effect on the bacterial burden 
(Fig. 6 B). These results indicate that Mtb-specific T reg cells 
but not T reg cells with irrelevant specificities can impair   
immunity and increase the lung bacterial load in TB. The po-
tency of Mtb-specific T reg cells is highlighted by the fact that 
when identical numbers of either Mtb-specific T reg cells or 
Mtb-specific conventional CD4+ T cells were transferred into 
infected mice, only T reg cells had an impact on the bacterial 
load (Fig. 6 B).
Pathogen-specific T reg cells delay the appearance  
of IFN-–producing effector T cells in the lung
Our data indicate that pathogen-specific T reg cells interfere 
with the initial immune control of Mtb infection, but we 
wondered how even small numbers of cells (i.e., 4–10 × 104 
cells transferred, of which only 40% expressed KN7 and were 
Mtb specific) could mediate such profound effects on the   
mycobacterial burden. Because establishing immune control 
is tightly correlated with the rapid appearance of Mtb-specific 
effector T cells in the lung (Cooper, 2009), we hypothesized 
that pathogen-specific T reg cells may compromise the   
protective immune response by delaying the arrival of these 
cells. To investigate this idea, we used MHC class II and I tet-
ramers to track CD4+ and CD8+ T cells recognizing immu-
nodominant MHC class II (i.e., ESAT-64–17:I-Ab) and I (i.e., 
TB10.44–11:Kb)–restricted  epitopes  in  Mtb-infected  mice.   
T reg cells (CD4+CD25+ cells) or conventional CD4+ T cells 
(CD4+CD25neg cells) from P25 mice were transferred into 
Mtb  (WT)–infected  Foxp3-GFP  mice,  and  an  additional 
group of controls received no transferred cells. Multiple time 
points during early Mtb infection were examined to assess the 
rate of effector T cell expansion and accumulation in the pLNs 
proliferate during TB unless the infecting strain of Mtb ex-
pressed Ag85B. Eightfold more transferred cells expressing 
Foxp3 were found in the spleens of WT-infected mice   
than in Ag85B KO–infected mice (Fig. 5 A). In Mtb (WT)– 
infected mice, 93% of these T reg cells had fully diluted their 
CFSE and continued to express high levels of the transgenic 
TCR. In contrast, very few P25 T reg cells diluted their CFSE 
in uninfected or Ag85B KO–infected mice, and very few 
SMARTA T reg cells diluted their CFSE in Mtb (WT)– 
infected mice. Similar results were observed in the pLNs and 
lungs; increased numbers of the Ag85B-specific T reg cells 
were seen in Mtb (WT)– but not Mtb (Ag85B KO)–infected 
or uninfected mice. Likewise, very few SMARTA T reg 
cells were recovered in the pLN and lung (Fig. 5 B). We 
conclude that inflammation induced by Mtb infection is   
not sufficient to drive the nonspecific proliferation of all 
CD4+Foxp3+ cells, but T reg cells recognizing Mtb antigens 
undergo preferential expansion.
Pathogen-specific T reg cells impair protective immunity
We next asked whether pathogen specificity enhanced the 
ability of T reg cells to suppress protective immunity during 
TB. Using a T reg cell transfer strategy similar to the one used 
to examine proliferation (Fig. 5), CD4+CD25+ T cells from 
P25 mice were transferred into B6 mice infected with Mtb 
(WT) or Mtb (Ag85B KO), as controls. We chose day 11 after 
infection as the day of transfer because it represents a time 
point at which Mtb has recently been transported from the 
lung to the pLN (Wolf et al., 2007; Chackerian et al., 2002; 
Reiley et al., 2008) but T cell expansion has not been initiated 
(Fig. 3). The lung bacterial burdens were assessed at two time 
points: day 21 after infection was examined because it is the 
critical time when the adaptive immune response begins to 
control Mtb in the lung (Cooper, 2009), whereas day 35 rep-
resents a later time that is often used to assess protective   
immunity in vaccine studies (Orme, 2005). Two additional 
controls were included at the later time point: Mtb (WT)– 
infected mice received CD4+CD25neg cells from P25 mice   
or CD4+CD25+ T cells from SMARTA mice. At both time 
Figure 4.  P25 mice contain a population of pathogen-specific T reg cells. (A) Expression of Foxp3 and transgenic TCR (detected by KN7  
antibody) on CD4-gated spleen cells from P25 mice on WT B6 or RAG2/ (bottom) backgrounds. The percentage of cells within each quadrant is 
shown. (B) Expression of the indicated markers by CD4-gated spleen cells from B6 mice (top) or KN7+CD4+ spleen cells from P25 mice (bottom).  
Numbers represent the frequency of cells in the indicated quadrants. The experiment was performed twice with three mice per group in each  
experiment. Results from representative mice are shown.1414 Mtb-specific T reg cells impair TB immunity | Shafiani et al.
levels seen in control groups; no differences in either ESAT-6–   
or TB10.4-specific T cells were seen in the pLN by day 21, or 
in the lung by day 30 after infection.
In addition to tetramer analysis, we performed intracellular 
cytokine  staining  to  assess  the  ability  of  ESAT-6–  and 
TB10.4-specific T cells to produce IFN- after in vitro stim-
ulation. We observed a delay in IFN-–producing T cells at 
early time points that was similar to our observations using 
tetramer staining (Fig. S4). Thus, transferred Mtb-specific   
T reg cells primarily interfered with the expansion of effector 
T cells and had minimal effect on IFN- production by ex-
isting effector T cells. Collectively, our data show that the 
capacity of small numbers of pathogen-specific T reg cells to 
deter immune control of Mtb infection is associated with de-
layed expansion of Mtb-specific, CD4+ and CD8+ T cells in 
the pLN, and delayed arrival of these effector T cells at the 
primary site of infection in the lung.
DISCUSSION
Our results show that small numbers of Mtb-specific T reg 
cells, even in the midst of an abundance of endogenous poly-
clonal T reg cells, are uniquely capable of impairing protec-
tive immunity by delaying the arrival of effector T cells to the 
and lungs. Mice receiving P25 T reg cells had delayed expan-
sion of both ESAT-6–specific CD4+ (Fig. 7, A and B) and 
TB10.4-specific CD8+ T cells (Fig. 7, C and D) in the pLN 
and lung. On average, mice receiving P25 T reg cells con-
tained approximately fourfold fewer ESAT-6–specific CD4+ 
T cells in the pLN on day 17 (Fig. 7 B and Fig. S1 A), and 
threefold fewer cells in the lungs on days 17 and 21 after in-
fection (Fig. 7 B). Importantly, the ESAT-6–specific CD4+  
T cells were not T reg cells because they did not express Foxp3 
(Fig. S2 and not depicted). In preliminary data, we found that 
transfer of fivefold higher numbers of Mtb-specific T reg cells 
caused an even greater reduction in the number of ESAT-6–
specific CD4+ T cells recovered from the lungs of day 17 
Mtb-infected mice (Fig. S3), suggesting that the ability of 
Mtb-specific T cells to suppress expansion of effector T cells is 
dose dependent. Interestingly, Mtb-specific CD8+ T cell re-
sponses occurred earlier than CD4+ responses, and T reg cell–
mediated reductions in CD8+ effector T cell numbers were 
more marked. Mice receiving P25 T reg cells contained   
7–10-fold fewer TB10.4-specific CD8+ T cells in the pLN   
(Fig. 7 D and Fig. S1 B) and 4–6-fold fewer cells in the lungs 
on days 14 and 17 after infection (Fig. 7 D). In preliminary 
data, effector CD4+ and CD8+ T cells eventually increased to 
Figure 5.  Preferential expansion of T reg cells recognizing Mtb-derived antigens. (A, top) Expression of Foxp3 and CD45.2 on gated CD4+  
CD45.2-enriched spleen cells from Mtb (WT)–infected, Mtb (Ag85B KO)–infected, or uninfected mice receiving 105 CFSE-labeled CD4+CD25+ T cells from 
P25 or SMARTA TCR transgenic mice, as indicated. T reg cells were transferred on day 15 and analyzed on day 20 after infection. Numerical values rep-
resent the absolute number of CD45.2 CD4+ Foxp3+ cells recovered from the spleen of a representative mouse from each group. (middle) The degree  
of proliferation (CFSE dilution) exhibited by these cells. (bottom) Expression of transgenic TCR (i.e., KN7 for P25 and V2 for SMARTA T reg cells) and CFSE. 
Numbers represent the frequency of cells in each quadrant. (B) Circles represent the absolute number of antigen-specific P25 or SMARTA T reg cells  
recovered from the pLN (top) or lung (bottom) from individual mice, and bars indicate the mean of each group. The experiment was performed three 
times with three mice per group in each experiment. Results from representative mice are shown in A. An unpaired Student’s t test was performed,  
and p-values for groups significantly different from the Mtb (WT) + P25 CD4+CD25+ group are indicated (*, P < 0.05; **, P < 0.001).JEM VOL. 207, July 5, 2010 
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because of the confounding influence of autoimmune activa-
tion that is inherently induced using these approaches (Kim   
et al., 2007). In this study, we circumvented this problem by 
transferring small numbers of T reg cells from TCR transgenic 
mice into recipients with normal numbers of endogenous   
T reg cells, allowing the effects of antigen-specific T reg cells 
to be studied in the absence of autoimmunity. It is noteworthy 
that our work finds an opposite role for T reg cells to a recent 
report that concluded that T reg cells help facilitate effector   
T cell recruitment to tissue sites of infection (Lund et al., 2008). 
These contrasting results could be explained by the differences 
in T reg cell function in viral versus mycobacterial infection, or 
because of the presence versus absence of autoimmune cyto-
kine release in LNs, an occurrence that may disrupt the chemo-
kine gradient required to recruit effector T cells to tissue sites 
of inflammation.
We found that T reg cells specific for Mtb Ag85B240–254 
delay  the  priming  of  effector  T  cells  recognizing  different 
MHC class I (TB10.44–11) and II (ESAT-64–17)–restricted Mtb 
epitopes in the pLN and their subsequent accumulation in the 
lung (Fig. 7 and Fig. S1). Previous studies investigating the   
effects of T reg cells on dendritic cell function may provide a 
framework for understanding how relatively small numbers of 
T reg cells can restrict the expansion of effector T cells, includ-
ing T cells recognizing epitopes that are distinct from the epit-
ope recognized by the T reg cells. Interaction between activated 
T reg cells and dendritic cells results in the down-regulation of 
CD80/86 expression on dendritic cells, impairing their capaci-
ties to deliver co-stimulatory signals and to establish lasting in-
teractions with naive T cells. These effects depend not only on 
CTLA-4 and LFA-1 but also on TCR-mediated signals (Onishi 
et al., 2008; Wing et al., 2008). Thus, it is likely that T reg cells 
recognizing antigens presented by the dendritic cells would 
preferentially mediate this activity. If T reg cells recognizing 
Mtb antigens are among the first T cells to specifically inter-
act with Mtb-infected dendritic cells in the pLN, the ability of 
these dendritic cells to subsequently prime effector T cells may 
be compromised.
Although we found no evidence for early induction of 
Foxp3 by non–T reg cells in B6 mice infected with the H37Rv 
strain of Mtb, in the future it will be important to look at later 
time points during persistent infection, as it is possible that 
chronic antigenic stimulation could induce Foxp3 expression 
in effector CD4+ T cells. In addition, it is possible that genetic 
differences in the infecting strain or the host could influence 
this outcome. A recent report indicates that a hypervirulent 
strain of Mtb (HN878) induces 10-fold higher numbers of   
T reg cells in the lung (Ordway et al., 2007). It is not known 
whether this strain is more efficient in expanding preexisting   
T reg cells or is uniquely capable of inducing T reg cells de novo. 
Conversely, some individuals may possess genetic polymor-
phisms that promote the expansion or generation of T reg cells 
in the periphery. For example, some humans infected with 
malaria were found to exhibit higher TGF- and T reg   
responses in their peripheral blood, and these individuals 
also had a faster parasitic growth rate (Walther et al., 2005). 
primary site of infection. These findings may help explain an 
important paradox in the field: despite the central importance 
of IFN-–producing T cells in immunity to Mtb, multiple 
studies have now demonstrated that the frequency of these 
cells in the periphery of immunized individuals correlates 
poorly with the degree of protection conferred (Leal et al., 
2001; Elias et al., 2005; Fletcher, 2007; Mittrücker et al., 
2007). Instead of the size of the peripheral population, a 
growing body of literature suggests that a cardinal feature of 
protective immunity is the rate at which IFN-–producing 
CD4+ T cells reach the lung (Cooper, 2009). The factors that 
regulate this recruitment, however, are only beginning to be 
elucidated. Recently, Mtb-specific Th17 cells were shown to 
be important for the rapid recruitment of Th1 effector cells 
to the lungs of immunized mice (Khader et al., 2007). Our 
data reveal that Mtb-specific T reg cells have an opposite effect, 
retarding this recruitment.
Previous studies have investigated T reg cell function dur-
ing infection by globally depleting T reg cells using antibodies 
(Scott-Browne et al., 2007), transferring naive T cells depleted 
of T reg cells into lymphopenic mice (Kursar et al., 2007), or 
administering diphtheria toxin to conditional knockin mice 
expressing diphtheria toxin receptor in T reg cells (Lund et al., 
2008). These experiments can sometimes be difficult to interpret 
Figure 6.  Pathogen-specific T reg cells suppress protective  
immunity in TB. (A) Day 21 lung CFU analysis of Mtb (WT)– or Mtb 
(Ag85B KO)–infected mice that received either no T cells or CD4+CD25+  
T cells from P25 mice intravenously on day 11 after infection (4 × 104 
cells/mouse). (B) Day 35 lung CFU analysis of Mtb (WT)– or Mtb (Ag85B 
KO)–infected mice that received either no T cells or P25 CD4+CD25+, 
SMARTA CD4+CD25+, or P25 CD4+CD25neg T cells intravenously on day 11 
after infection (105 cells/mouse), as indicated. Circles represent individual 
mice and bars represent the mean of each group (*, P < 0.01,  
unpaired Student’s t test). The experiment was performed three times at 
day 21 and once at day 35 with five mice per group in each experiment.1416 Mtb-specific T reg cells impair TB immunity | Shafiani et al.
mediated signals that have previously been shown to restrict   
T reg cell activation during inflammatory responses (Pasare and 
Medzhitov, 2003, 2004; Yang et al., 2004; Peng et al., 2005). 
Furthermore, we hypothesize that high affinity interactions 
with Mtb antigens presented in the pLN enable clonal popula-
tions of Mtb-specific T reg cells to overcome this restriction. 
In support of this idea, our data clearly show that despite being 
a highly activated population of T cells expressing the high af-
finity IL-2R (CD25; Sakaguchi et al., 2008), not all T reg cells 
are equally capable of responding during the inflammatory   
milieu of TB. Mtb-specific T reg cells, compared with a poly-
clonal population of T reg cells, displayed a greatly enhanced 
ability to proliferate and suppress protective immunity. These 
results, however, do not exclude the possibility that relatively 
rare clonal populations of self-reactive T reg cells might also 
undergo expansion and contribute to immunoregulation.
The fact that we did not detect Foxp3+ cells specific for 
ESAT-64–17:I-Ab, the immunodominant Mtb epitope for   
effector CD4+ T cells in B6 mice, further supports our finding 
Further studies are needed to determine if bacterial and host 
genetic factors governing expansion or de novo generation of 
T reg cells are correlated with impaired immune control of 
Mtb and rapid progression of TB.
Consistent with previous findings during Leishmania infec-
tion (Belkaid et al., 2002; Suffia et al., 2006), we found that   
T reg cells responding to early Mtb infection arise from the 
population of preexisting T reg cells that expressed Foxp3 be-
fore infection. In addition, we observed that T reg cells in the 
pLN and lung do not undergo enhanced proliferation until at 
least 16 d after infection. This delay parallels the previously de-
scribed delay in proliferation of conventional CD4 T cells that 
occurs only after Mtb is transported to the pLN and presenta-
tion of Mtb antigens begins to occur at this site (Cooper, 2009). 
In the case of T reg cells located in the lung, we find that not 
only is proliferation delayed until after day 16, but in compari-
son to lung T reg cells in uninfected mice, proliferation is 
actually diminished before this time. We speculate that this 
diminished proliferation is mediated by Toll-like receptor– 
Figure 7.  Mtb-specific T reg cells delay effector T cell expansion. (A) Representative expression of CD44 and binding to ESAT-64–17:I-Ab tetramers 
by CD3+CD4+-gated T cells in the lungs of Mtb (WT)–infected B6 mice on day 21 after infection. As indicated, mice received no T cells or P25 CD4+CD25+ 
or P25 CD4+CD25neg T cells (105 cells/mouse) intravenously on day 11 after infection. Numerical values represent the percentage of cells binding the  
tetramer. (B) Cumulative data showing the absolute numbers of ESAT-64–17:I-Ab tetramer–binding cells in the pLNs and lungs at different time points  
after Mtb infection. Circles represent individual mice and bars represent the mean of each group. (C) Representative expression of CD44 and binding to 
TB10.44–11:Kb tetramers by CD3+CD8+-gated T cells in the lungs of Mtb (WT)–infected B6 mice on day 17 after infection in the same experiment depicted 
in A and B. Numerical values represent the percentage of cells binding the tetramer. (D) Cumulative data showing the absolute numbers of TB10.44–11:Kb 
tetramer–binding cells in the pLNs and lungs at different time points after Mtb infection. Circles represent individual mice and bars represent the mean  
of each group. The unpaired Student’s t test was performed, and p-values for groups significantly different from the group receiving no T cells are shown. 
The experiments were performed twice at day 17 and once at other time points.JEM VOL. 207, July 5, 2010 
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Bacillus Calmette-Guérin (BCG; an attenuated strain of 
M. bovis), the currently used TB vaccine, has demonstrated 
widely disparate degrees of efficacy in different studies, from   
0 to 80% (Andersen and Doherty, 2005). Interestingly, some 
epidemiological studies have concluded that BCG performs 
relatively well in industrialized countries with lower levels of 
exposure to NTM in the environment but performs poorly, if 
at all, in the developing world where individuals have higher 
levels of exposure (Fine, 1995; Black et al., 2002; Andersen 
and Doherty, 2005; Weir et al., 2006). More studies are 
needed to verify this correlation, but it is tempting to specu-
late that frequent, high level oral exposure to environmental 
NTM induces populations of mycobacteria-specific T reg 
cells in the gut. Our results suggest that expanded numbers of 
mycobacteria-specific T reg cells that cross react with BCG 
and/or Mtb antigens would impede vaccine-induced immu-
nity against Mtb, and may help explain the failure of BCG   
in many parts of the world. Two recent mouse studies have 
shown that inactivation of T reg cells before immunization 
enhances BCG-induced T cell responses but only marginally 
improves, or does not improve, protection against Mtb (Quinn 
et al., 2006; Jaron et al., 2008). These studies, however, were 
performed in mice reared in relatively sterile environments 
that most likely would not have expanded populations of myco-
bacteria-specific T reg cells. Future studies are needed to de-
termine if oral exposure to NTM induce or expand populations 
of T reg cells that cross react with Mtb. If so, inactivation of 
T  reg  cells  before  booster  immunizations  may  provide  a 
greater benefit for protective immunity to TB in a natural set-
ting in which individuals may have increased numbers of my-
cobacteria-specific T reg cells. We propose that immunization 
and environmental exposures may expand not only protective 
T cell subsets, including Mtb-specific Th1 and Th17 cells, but 
also T cell subsets, such as Mtb-specific T reg cells, that im-
pede protection. An individual’s overall level of immune pro-
tection may depend on their relative ratio of protective versus 
suppressive T cell subsets.
MATERIALS AND METHODS
Mice. C57BL/6, C57BL/6.PL (CD90.1), and RAG2/ mice were pur-
chased from the Jackson Laboratory. B6.SJL-Ptprca/BoyAiTac (CD45.1) 
mice were purchased from Taconic. P25 TCR transgenic mice have been 
previously described (Tamura et al., 2004). SMARTA TCR transgenic mice 
and Foxp3-GFP mice (backcrossed 12 times to C57BL/6 mice) were pro-
vided by M. Bevan (University of Washington, Seattle, WA) and A. Rudensky 
(Memorial Sloan-Kettering Cancer Center, New York, NY), respectively. 
All mice were housed and bred under specific pathogen–free conditions at 
the University of Washington. All experimental protocols involving animals 
were approved by the Institutional Animal Care and Use Committee of the 
University of Washington.
Bacteria and aerosol infections. A stock of Mtb strain H37Rv or a strain 
of Mtb engineered to lack the expression of Ag85B (Mtb Ag85B KO; pro-
vided by J. Ernst, New York University, New York, NY) was sonicated be-
fore use, and mice were infected in an aerosol infection chamber (Glas-Col) 
with 50–100 CFU deposited in the lungs of each mouse. Two mice were 
sacrificed on day 1 after infection to determine the infectious dose in each ex-
periment. To determine viable numbers of CFUs, the left lung of each mouse 
was homogenized in PBS with 0.05% Tween 80. 10-fold serial dilutions were 
that Mtb-specific effector T cells do not convert into T reg 
cells, and also indicates that T reg cells expanding from the 
preexisting T reg cell population do not recognize this epitope. 
These results are also consistent with other reports in which 
MHC class II tetramers containing epitopes recognized by ef-
fector T cells failed to bind Foxp3+ cells (Antunes et al., 2008; 
Burchill et al., 2008). These findings, however, do not exclude 
the possibility that T reg cells recognize Mtb epitopes that do 
not overlap, or only partially overlap, with epitopes recognized 
by effector T cells. Conventional CD4+ T cells and T reg cells are 
both selected in the thymus via interactions with self-antigens 
(Piccirillo and Shevach, 2004; Fontenot and Rudensky, 2005), 
and conventional CD4+ T cells possess the ability to respond to 
foreign antigens in the periphery. The degree to which T reg 
cells respond to foreign antigens has not been well established, 
but T reg cells possess a TCR repertoire that is at least as di-
verse as that of conventional CD4+ T cells (Hsieh et al., 2006; 
Pacholczyk et al., 2007). Therefore, it seems likely that indi-
viduals possess populations of T reg cells recognizing most, if 
not all, microbes. Indeed, pathogen-specific T reg cells have 
been reported in a variety of infections (Belkaid and Tarbell, 
2009). Because T reg cells are selected in the thymus by higher 
affinity interactions with self-antigens than conventional CD4+ 
T cells (Hsieh et al., 2004; Bautista et al., 2009; DiPaolo and 
Shevach, 2009), it is possible that the foreign antigens that each 
T cell type recognizes will not be identical. In support of this idea, 
Suffia et al. (2006) have shown that T reg cells responding to 
L. major infection proliferate specifically to Leishmania-infected 
bone marrow–derived dendritic cells. However, despite being 
Leishmania specific, these T reg cells do not proliferate in response 
to immunodominant L. major epitopes recognized by effector 
T cells, suggesting that they recognize distinct Leishmania- 
specific epitopes (Belkaid, Y., personal communication).
An important implication of our data is that expanded pop-
ulations of preexisting T reg cells recognizing Mtb antigens 
may adversely affect an individual’s ability to mount a rapid 
and effective immune response to Mtb. Preexisting Foxp3+  
T cells are frequently considered to be “natural” T reg cells 
that develop intrathymically via interactions with self-antigens 
(Hsieh et al., 2004; Sakaguchi et al., 2008), though they could 
also represent CD4+ T cells induced to express Foxp3 extra-
thymically after environmental exposures or even by immuni-
zation (Belkaid, 2008). Induction of T reg cells in the periphery 
has been shown to occur most efficiently in the gut, a highly 
regulated immunological site where the immune system must 
tolerate constant exposure to commensal bacteria and food anti-
gens without mounting harmful inflammatory responses, and 
is facilitated by a population of tolerogenic dendritic cells in the 
gut-associated lymphoid tissue that releases bioactive TGF- 
(Coombes et al., 2007; Sun et al., 2007). Although this process 
may not be important to immune responses to Mtb in mice 
reared in a specific pathogen–free facility receiving sterilized 
food and water, it may be critical in human populations with 
frequent oral exposure to non-TB mycobacteria (NTM) shar-
ing many antigenic determinants with Mtb (Andersen and 
Doherty, 2005).1418 Mtb-specific T reg cells impair TB immunity | Shafiani et al.
The labeling reaction was quenched by washing in ice-cold RPMI 1640 
supplemented with 10% FCS. CFSE-labeled cells were injected intra-
venously into recipient mice. 5–7 d later, CD4+ T cells were isolated from 
lungs, spleen, and draining LN as described, and cell division as a measure 
of decrease in CFSE intensity was analyzed by flow cytometry. To detect 
the proliferation of endogenous T cells after Mtb infection, mice were ad-
ministered 1 mg of the thymidine analogue BrdU intraperitoneally and 
harvested 20 h later. After preparation of single-cell suspensions from pLNs 
and lungs, cells were stained for cell-surface markers. The BrdU flow kit 
(BD)  protocol  was  followed  for  intracellular  BrdU  staining  with  slight 
modifications to allow for Foxp3 costaining.
Detection of ESAT-64–17– and TB10.44–11–specific cells. PE-labeled 
MHC class II tetramers (I-Ab) containing the stimulatory residues 4 to 17 
(QQWNFAGIEAAASA)  of  the  early  secreted  antigenic  target  6  kD 
(ESAT-6) of Mtb were provided by M. Jenkins (University of Minnesota, 
Minneapolis, MN; Moon et al., 2007). APC-labeled MHC class I tetra-
mers (Kb) containing the stimulatory residues 4 to 11 (IMYNYPAM) of 
the low molecular weight protein antigen TB10.4 of Mtb were obtained 
from the National Institutes of Health Tetramer Core Facility. Single-cell 
preparations from lungs and pLNs were incubated for 1 h at room temper-
ature with 5–10 nM of ESAT-64–17:I-Ab tetramers in 1:1 Fc Block/sorter 
buffer, washed with sorter buffer, and incubated for 30 min on ice with 
TB10.44–11:Kb tetramers in 100 µl of sorter buffer at a dilution of 1:400. 
Lung cells were washed in sorter buffer and stained with PerCP-Cy5.5– 
labeled anti-CD3, Pacific orange–labeled anti-CD4 (Invitrogen), Alexa 
Fluor 700–labeled anti-CD44, APC–eFluor 780–labeled anti-CD8, and a 
Pacific  blue–labeled  non–T  cell  cocktail  containing  anti-F4/80,  anti-
CD19, anti-CD11c, and anti-CD11b. ESAT-64–17–specific T cells were 
identified as CD3+, non–T cell cocktail–negative, CD4+, CD8neg, tetra-
mer+, CD44hi events. Likewise, TB10.44–11–specific cells were identified as 
CD3+, non–T cell cocktail–negative, CD4neg, CD8+, tetramer+, CD44hi 
events. Because of the lower frequency of antigen-specific T cells in the 
LNs,  after  the  tetramer  staining  steps,  the  pLNs  were  coenriched  for 
ESAT-64–17– and TB10.44–11:Kb–specific cells by incubation with sorter 
buffer  containing  anti-PE–  and  anti-APC–conjugated  magnetic  micro-
beads (Miltenyi Biotec) on ice for 30 min and passing over a magnetized 
LS column. The column was washed with sorter buffer and removed from 
the magnetic field. The bound fraction was obtained by pushing 5 ml of 
sorter buffer through the column with a plunger. The enriched fractions 
were stained with other surface markers as described for lungs.
Online supplemental material. Fig. S1 shows representative flow cytomet-
ric plots demonstrating that Mtb-specific T reg cells restrict the LN priming of 
Mtb-specific CD4+ and CD8+ T cells, as defined by MHC class II and I tet-
ramers, respectively, during early Mtb infection. Fig. S2 shows that tetramer- 
binding Mtb-specific CD4+ T cells do not express Foxp3 during early 
Mtb infection. Fig. S3 shows that transfer of high numbers of Mtb-specific   
T reg cells mediates an increased reduction in the appearance of effector   
T cells in the lungs of recipient mice. Fig. S4 shows that Mtb-specific T reg 
cells delay the appearance of IFN-–producing CD4+ and CD8+ effector   
T cells in the lungs of recently Mtb-infected mice. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20091885/DC1.
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made in PBS with 0.05% Tween 80 and plated on Mitchison 7H10 plates. 
Colonies were counted after 21 d of incubation at 37°C, and CFUs per organ 
were determined.
Cell enrichment and sorting. For adoptive transfer experiments, CD4+ 
T cells were negatively enriched to >95% purity from freshly isolated spleen 
and LN cells using magnetic microbeads and subsequent column purifica-
tion according to the manufacturer’s protocol (Miltenyi Biotec). In some 
experiments the cells were stained by PE-conjugated anti-CD25 antibody 
and then sorted for the CD25hi or CD25neg fraction, whereas in other ex-
periments Foxp3-GFP+ and Foxp3-GFPneg cells were sorted on a cell sorter 
(FACSAria or FACSVantage; BD). Sorted cells were analyzed for purity and 
adoptively transferred into mice.
Cell-surface  staining. Single-cell suspensions of intraparenchymal lung 
lymphocytes were prepared by Liberase Blendzyme 3 (Roche) digestion of 
perfused lungs in the presence of the inducible nitric oxide synthase inhibitor 
aminoguanidine (Sigma-Aldrich), as previously described (Urdahl et al., 
2003). Cells from spleens and LNs were prepared as previously described 
(Urdahl et al., 2003). Fc receptors were blocked with anti-CD16/32 (2.4G2). 
Cells were suspended in PBS containing 0.1% NaN3 and 2.5% fetal bovine 
serum (i.e., sorter buffer) and stained at saturating conditions using antibod-
ies specific for CD3 (145-2C11), CD4 (RM4-5), CD8 (53-6.7), CD25 
(PC61), GITR (DTA-1), CD103 (M290), CTLA-4 (UC10-4F10-11), and 
V2 (B20.1) obtained from BD, or F4/80 (BM8), CD11b (M1/70), CD11c 
(N418), CD19 (eBio1D3), CD44 (1M7), Thy1.1 (HIS51), Thy1.2 (53-2.1), 
CD45.1 (A20), and CD45.2 (104) obtained from eBioscience. For the de-
tection of P25 transgenic cells, we used the rat anti–mouse clonotypic TCR 
mAb KN7 that recognizes TCR expressed on the Ag85B240–254–reactive Th1 
clone of B6 mice. Samples were fixed in a 2% paraformaldehyde solution in 
PBS and analyzed using a FACSCanto or LSR II (both from BD) and FlowJo 
software (Tree Star, Inc.).
Detection of transferred cells by magnetic bead enrichment. For de-
tection of small numbers of transferred cells in an entire spleen, we used a 
magnetic bead enrichment technique recently described by Hataye et al. 
(2006). In brief, spleen cells from the entire spleen of each individual mouse 
were labeled with biotin-labeled anti-CD90.2 or anti-CD45.2 antibody, 
washed, labeled with streptavidin beads under nonsaturating conditions 
(Miltenyi Biotec),  and  passed  over  magnetized  LS  columns  (Miltenyi 
Biotec). After washing the columns to remove unlabeled cells, the columns 
were removed from the magnets and the bound cells were eluted. This en-
riched cell population was labeled with fluorochrome-conjugated streptavidin, 
and also for cell-surface and intracellular molecules, as outlined. The entire 
stained sample was analyzed as described in Cell-surface staining.
Intracellular staining. Intracellular IFN- staining was performed using 
a kit as instructed by the manufacturer (BD) with a few modifications. In 
brief, lung cells were stimulated with ESAT-64–17 peptide (5 µg/ml final 
concentration) or TB10.44–11 (0.5 µg/ml final concentration) for 4 h in 
complete  RPMI  (RPMI  1640  supplemented  with  10%  FCS,  2  mM   
l-glutamine, 10 mM Hepes, 0.5 µM 2-ME, 100 U/ml penicillin, and   
100 µg/ml streptomycin) in the presence of monensin. Cells were washed, 
stained with antibodies against surface markers, and fixed in 2% para 
formaldehyde.  Cells  were  subsequently  permeabilized  in  permeabili-
zation buffer (BD) and stained with anti–IFN-–allophycocyanin (APC; 
XMG1.2; BD). In some experiments, cells were permeabilized and stained 
for intracellular Foxp3 using anti-Foxp3–APC (FJK-16s) and an intracel-
lular staining kit according to the instructions provided by the manufac-
turer (eBioscience). Stained cells were acquired and analyzed as described 
in Cell-surface staining.
Analysis of cell proliferation. To track the division of adoptively trans-
ferred cells, isolated CD4+CD25+ T cells were stained in vitro with 5 µM 
CFSE (Invitrogen) followed by incubation for 10 min at 37°C with CFSE. JEM VOL. 207, July 5, 2010 
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